Inactive Instrument

Sector Chart Progenics Pharmaceuticals, Inc.

Equities

US7431871067

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
125B
109B
24.74B -
22.67B -
18.14B